Related Experiment Video

Updated: Jul 19, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

[Fibrinogen--acute phase protein as a marker of immunological process as atherosclerosis]

Renata Rajtari1, Małgorzata Kloch, Beata Kiec-Wilk

  • 1II Klinika Kardiologii Instytutu Kardiologii, Collegium Medicum Uniwersytetu Jagiellońskiego, Kraków.

Folia Medica Cracoviensia
|October 14, 2006
PubMed

Insights

Key coronary artery disease (CAD) risks include smoking, cholesterol levels, diabetes, and hypertension. Atherosclerosis is now understood as an immuno-inflammatory process, with fibrinogen emerging as a potential marker for ischemic heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Context:

  • Coronary artery disease (CAD) is a significant health concern.
  • Established risk factors for CAD include smoking, dyslipidemia (high LDL-cholesterol, low HDL-cholesterol), hypertriglyceridemia, diabetes, obesity, hypertension, male sex, and age.
  • Historical perspectives on atherosclerosis include Carl von Rokitański's thrombolic theory.

Purpose:

  • To review the established and emerging risk factors for coronary artery disease.
  • To highlight the immuno-inflammatory nature of atherosclerosis.
  • To introduce fibrinogen as a potential marker for ischemic heart disease.

Summary:

  • Major CAD risk factors encompass lifestyle choices (smoking), metabolic derangements (cholesterol, triglycerides, diabetes, obesity, hypertension), and demographics (sex, age).
  • Contemporary research increasingly characterizes atherosclerosis as an immuno-inflammatory condition, moving beyond purely thrombotic theories.
  • Fibrinogen, an acute phase protein, is identified as a novel potential biomarker for ischemic heart disease, warranting further investigation into its role in atherosclerosis.

Impact:

  • Provides a comprehensive overview of CAD risk factors, integrating traditional and novel insights.
  • Emphasizes the shift in understanding atherosclerosis as an immuno-inflammatory process.
  • Suggests new avenues for research and potential diagnostic markers for ischemic heart disease.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Inflammation01:38

Inflammation

Overview
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...